Detalhe da pesquisa
1.
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer.
N Engl J Med
; 389(22): 2063-2075, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861218
2.
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B.
Cancer
; 130(9): 1693-1701, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38165808
3.
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
Cancer
; 130(4): 541-552, 2024 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843249
4.
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION.
Br J Cancer
; 130(10): 1679-1686, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575731
5.
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma.
Cancer Immunol Immunother
; 73(4): 70, 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38430375
6.
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.
Future Oncol
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38357801
7.
A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer.
Int J Cancer
; 153(8): 1501-1511, 2023 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37357950
8.
A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomas.
Cancer
; 129(19): 2966-2974, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246414
9.
Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance.
Mod Pathol
; 36(7): 100184, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37054974
10.
Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early-stage lung adenocarcinoma.
Histopathology
; 83(2): 168-177, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849852
11.
Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Cancer
; 128(11): 2148-2158, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35319779
12.
Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11).
Cancer
; 128(4): 778-787, 2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34705268
13.
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer.
Eur J Immunol
; 51(4): 956-964, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33506525
14.
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell lung cancer.
Invest New Drugs
; 40(2): 265-273, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973117
15.
Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor.
Oncology
; 100(4): 228-237, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196661
16.
Encorafenib plus binimetinib in patients with BRAFV600-mutant non-small cell lung cancer: phase II PHAROS study design.
Future Oncol
; 18(7): 781-791, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918546
17.
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Cancer
; 127(16): 3019-3028, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826761
18.
Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 379(21): 2027-2039, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280657
19.
MDSC subtypes and CD39 expression on CD8+ T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC.
Eur J Immunol
; 50(11): 1810-1819, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32510574
20.
SIDR: simultaneous isolation and parallel sequencing of genomic DNA and total RNA from single cells.
Genome Res
; 28(1): 75-87, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29208629